{"document": {"publication": "Tag My News", "full_text": "bristol-myers squibb co's eagerly anticipated experimental drug ipilimumab extended survival of previously untreated patients with advanced melanoma in a late stage study, the company said.", "title": "bristol melanoma drug extends survival in study", "line_count": 1, "filename": "25200", "publication_date": "22-03-2011 13:11:26", "lines_and_colors": [["bristol-myers squibb co's eagerly anticipated experimental drug ipilimumab extended survival of previously untreated patients with advanced melanoma in a late stage study, the company said.", {}]]}}